Bladder Cancer Market Likely to Exhibit Substantial Growth, Assesses DelveInsight | Leading Companies – CicloMed, Bristol-Myers Squibb, CG Oncology, Merck, Eli Lilly and Company, UroGen, Ferring

The dynamics of the bladder cancer market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the disease, incremental healthcare spending worldwide, and the expected launch of emerging therapies. LAS VEGAS, Aug. 7,…